Kamada (KMDA) EPS (Weighted Average and Diluted) (2012 - 2026)

Kamada (KMDA) reported EPS (Weighted Average and Diluted) of $59028.6 for Q1 2026, down 55.39% on a YoY basis from $132314.3 in Q1 2025, and up 249.81% quarter-over-quarter from $16874.3 in Q4 2025.

Kamada (KMDA) EPS (Weighted Average and Diluted) (2012 - 2026) Analysis & Trends

Kamada has reported EPS (Weighted Average and Diluted) for 15 years, with the latest figure at $59028.6 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 55.39% year-over-year to $59028.6; the trailing twelve-month figure through Mar 2026 stood at $59028.6 (down 55.39% YoY), and the FY2025 full-year result was $76388.6, up 56.46% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at $59028.6, up from $16874.3 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $132314.3 in Q1 2025, with the low at -$45700.0 in Q1 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged $25938.4 across 5 years, with a median of $22394.4 in 2024.
  • Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) tumbled 357.52% — and 2024, when it surged 139016.53%.
  • Kamada's EPS (Weighted Average and Diluted) stood at $42057.1 in 2022, then retreated by 19.82% to $33720.0 in 2023, then plunged by 54.83% to $15232.0 in 2024, then advanced by 10.78% to $16874.3 in 2025, then soared by 249.81% to $59028.6 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $59028.6 (Q1 2026), $16874.3 (Q4 2025), and $29120.7 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.31
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 1.42
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 5.82
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.02
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.91
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.11
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -0.40
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.80
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -0.40
10 Kamada 505.05 -73.15 Mn 19.12 Mn 59,028.57

Historic Data

Download Data
DateValue
Mar 31, 2026 59,028.57
Dec 31, 2025 16,874.29
Sep 30, 2025 29,120.69
Jun 30, 2025 21.74
Mar 31, 2025 132,314.29
Dec 31, 2024 15,232.00
Sep 30, 2024 22,394.44
Jun 30, 2024 -487.59
Mar 31, 2024 62,825.00
Dec 31, 2023 33,720.00
Sep 30, 2023 53,716.67
Jun 30, 2023 45,925.00
Mar 31, 2023 -45.23
Dec 31, 2022 42,057.14
Sep 30, 2022 4,116.58
Jun 30, 2022 -30,161.54
Mar 31, 2022 -45,700.00
Dec 31, 2021 -42,400.00
Sep 30, 2021 -14,083.33
Jun 30, 2021 11,712.50